1. Office of the Commissioner. Combination products. U.S. Food and Drug Administration. https://www.fda.gov/combination-products. Accessed September 1, 2021.
2. Office of the Commissioner. Combination product definition combination product types. U.S. Food and Drug Administration. https://www.fda.gov/combination-products/about-combination-products/combination-product-definition-combination-product-types. Accessed September 1, 2021.
3. Office of the Commissioner. Classification of products as drugs and devices and additional issues. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/classification-products-drugs-and-devices-and-additional-product-classification-issues#drug. Accessed September 1, 2021.
4. Office of the Commissioner. Early development considerations for innovative combination products. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/early-development-considerations-innovative-combination-products. Accessed September 1, 2021.
5. Updated Use of TACE for Hepatocellular Carcinoma Treatment: How and when to Use it Based on Clinical Evidence. Cancer Treatment Reviews, 72;Raoul,2019